Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Jan 18, 2006 by Edgar Snyder

Hemophilia Drug Can Cause Complications

Hemophilia Drug

The off-label usage of a drug that treats bleeding in hemophiliacs has been linked to deaths, strokes, heart attacks, and other complications, according to the Food and Drug Administration (FDA).

NovoSeven was approved by the FDA in 1999 as a clotting drug for use in hemophiliacs. Later the drug showed potential for treating cerebral hemorrhages, a serious stroke that causes bleeding in the brain, but NovoSeven was not approved by the FDA to treat this type of condition.

Novo Nordisk, makers of the drug, say off-label use of NovoSeven has affected older people and those with underlying heart disease. The risk for FDA approved use of the drug for hemophiliacs is said to be low.

For more information about recalled drugs, visit our Dangerous Drug and Recall Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “Hemophilia Drug Is Linked to Deaths In Off-Label Uses.” The Associated Press. The Wall Street Journal. January 18, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Sep 14, 2016
PA Residents: You're This Much More Likely to Hit a Deer